BALDUZZI ADRIANA CRISTINA

Manghisi, B., Cotilli, G., Fedele, M., Perfetti, P., Terruzzi, E., Verga, L., et al. (2025). Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy. FRONTIERS IN IMMUNOLOGY, 16 [10.3389/fimmu.2025.1563736]. Detail

Ince, E., Galimard, J., Ifversen, M., Dalissier, A., Szmit, Z., Mirci-Danicar, O., et al. (2025). Donor cytomegalovirus serology impacts overall survival in children receiving first unrelated hematopoietic stem cell transplant for acute leukemia: European Society of Bone Marrow Transplantation Pediatric Diseases Working Party Study. HAEMATOLOGICA, 110(4), 985-989 [10.3324/haematol.2024.286082]. Detail

Orti, G., Peczynski, C., Boreland, W., O'Reilly, M., von Bonin, M., Balduzzi, A., et al. (2025). Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study. LEUKEMIA, 39(2), 431-437 [10.1038/s41375-024-02467-5]. Detail

Lussana, F., Magnani, C., Galimberti, S., Gritti, G., Gaipa, G., Belotti, D., et al. (2025). Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation. BLOOD CANCER JOURNAL, 15(1) [10.1038/s41408-025-01260-6]. Detail

Kałwak, K., Moser, L., Pötschger, U., Bader, P., Kleinschmidt, K., Meisel, R., et al. (2025). Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUM. BLOOD ADVANCES, 9(4), 741-751 [10.1182/bloodadvances.2024014548]. Detail